Variant report
Variant | nsv946147 |
---|---|
Chromosome Location | chr1:104482215-104490017 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555014680 | chr1:104483810-104483811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs3849298 | chr1:104483838-104483839 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs541327982 | chr1:104483839-104483840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529155553 | chr1:104483895-104483896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543570130 | chr1:104483897-104483898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4520426 | chr1:104483941-104483942 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs578199371 | chr1:104483973-104483974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7554165 | chr1:104483975-104483976 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs188763102 | chr1:104483987-104483988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200654797 | chr1:104484004-104484005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530981206 | chr1:104484042-104484043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192693049 | chr1:104484069-104484070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561094012 | chr1:104484084-104484085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116524396 | chr1:104484089-104484090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7545401 | chr1:104484099-104484100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs565684668 | chr1:104484102-104484103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532953352 | chr1:104484180-104484181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150137092 | chr1:104484217-104484218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185035065 | chr1:104484233-104484234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138569225 | chr1:104484237-104484238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555454904 | chr1:104484247-104484248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567136160 | chr1:104484343-104484344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551284 | chr1:104484407-104484408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs370776637 | chr1:104484410-104484411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578259570 | chr1:104484428-104484429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545723762 | chr1:104484431-104484432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115718695 | chr1:104484472-104484473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78691055 | chr1:104484485-104484486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542742598 | chr1:104484500-104484501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149330330 | chr1:104484501-104484502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs662162 | chr1:104484628-104484629 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs548714 | chr1:104484630-104484631 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs564948551 | chr1:104484634-104484635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61816494 | chr1:104484650-104484651 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs530885562 | chr1:104484665-104484666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372326781 | chr1:104484666-104484667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77810808 | chr1:104484680-104484681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11465131 | chr1:104484681-104484682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79476985 | chr1:104484682-104484683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75359743 | chr1:104484683-104484684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144575450 | chr1:104484713-104484714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530767135 | chr1:104484775-104484776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548779630 | chr1:104484783-104484784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567399415 | chr1:104484834-104484835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534311428 | chr1:104484846-104484847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546576938 | chr1:104484919-104484920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7548445 | chr1:104484934-104484935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs539306799 | chr1:104484947-104484948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7516686 | chr1:104484953-104484954 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs575888555 | chr1:104484973-104484974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104483800-104484800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr1:104483800-104485800 | Enhancers | Fetal Lung | lung |
3 | chr1:104484000-104484400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:104484200-104485000 | Enhancers | Pancreas | Pancrea |
5 | chr1:104485400-104486000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr1:104485800-104487400 | Weak transcription | Fetal Lung | lung |
7 | chr1:104487400-104487600 | Enhancers | Fetal Lung | lung |
8 | chr1:104488400-104488600 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr1:104488600-104488800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |